Published in Viral Immunol on January 01, 2006
B cells in HIV infection and disease. Nat Rev Immunol (2009) 4.73
Compartmentalization of innate immune responses in the central nervous system during cryptococcal meningitis/HIV coinfection. AIDS (2014) 0.98
Induction of a Soluble Anti-HIV-1 factor (s) with IFN-γ, IL-10, and β-Chemokine Modulating Activity by an Influenza-Bacterial Polyantigenic Mixture. Am J Infect Dis (2007) 0.75
Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages. J Exp Med (1995) 3.36
Hepatitis C virus genotyping by means of 5'-UR/core line probe assays and molecular analysis of untypeable samples. Virus Res (1995) 2.14
Transmission of hepatitis B virus by HBV-negative blood transfusion. Lancet (1995) 2.06
Acute cytomegalovirus infection and venous thrombosis: role of antiphospholipid antibodies. J Infect (2006) 1.73
Capacity of the clinical picture to characterize low back pain relieved by facet joint anesthesia. Proposed criteria to identify patients with painful facet joints. Spine (Phila Pa 1976) (1998) 1.71
Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment. Diabetes Care (1998) 1.59
Alterations of monocyte function in patients with growth hormone (GH) deficiency: effect of substitutive GH therapy. J Clin Endocrinol Metab (1999) 1.58
Surgical management of brain-stem tumors in children: results and statistical analysis of 75 cases. J Neurosurg (1993) 1.50
Hepatitis virus infections in heart transplant recipients: epidemiology, natural history, characteristics, and impact on survival. Gastroenterology (2000) 1.47
Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus. Gut (1999) 1.44
Impact of TT virus infection in acute and chronic, viral- and non viral-related liver diseases. J Hepatol (2000) 1.40
Non-organ specific autoantibodies associated with chronic C virus hepatitis. J Hepatol (1993) 1.39
Evaluation and improvement of a reliable diagnosis of cirrhosis by blood tests. Gastroenterol Clin Biol (2008) 1.39
[Eradication of hepatitis C virus after 3 months of interferon treatment in a patient with chronic hepatitis C]. Gastroenterol Clin Biol (2000) 1.38
Titrated mandibular advancement versus positive airway pressure for sleep apnoea. Eur Respir J (2009) 1.30
Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity. J Gen Virol (1998) 1.27
Specific interaction of Aspergillus fumigatus with fibrinogen and its role in cell adhesion. Infect Immun (1994) 1.22
Genetic diversity of the hepatitis C virus: impact and issues in the antiviral therapy. World J Gastroenterol (2007) 1.22
In-vivo selection of an azole-resistant petite mutant of Candida glabrata. J Med Microbiol (2000) 1.19
Comparative evaluation of hepatitis C virus RNA quantitation by branched DNA, NASBA, and monitor assays. Hepatology (1999) 1.17
Novel DNA assay for cytomegalovirus detection: comparison with conventional culture and pp65 antigenemia assay. J Clin Microbiol (1996) 1.17
Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy. The GEMHEP. J Viral Hepat (1999) 1.16
Expression and identification of a laminin-binding protein in Aspergillus fumigatus conidia. Infect Immun (1997) 1.16
Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in French patients. J Hepatol (1997) 1.15
Protection against malaria induced by irradiated sporozoites. Lancet (1990) 1.10
Comparison of seven staining methods for senile plaques and neurofibrillary tangles in a prospective series of 15 elderly patients. Neuropathol Appl Neurobiol (1990) 1.08
Clinical and spectroscopic improvement in HIV-associated cognitive impairment. Neurology (2001) 1.07
Detection of genomic viral RNA in nerve and muscle of patients with HCV neuropathy. Neurology (2003) 1.07
Professional and medical outcomes for French train drivers after "person under train" accidents: three year follow up study. Occup Environ Med (2004) 1.05
Direct regulatory effect of fatty acids on macrophage lipoprotein lipase: potential role of PPARs. Diabetes (2001) 1.02
Prenatal exposure to influenza as a risk factor for adult schizophrenia. Acta Psychiatr Scand (2003) 1.01
Essential mixed cryoglobulinemia. A comparative study of dermatologic manifestations in patients infected or noninfected with hepatitis C virus. Arch Dermatol (1995) 1.01
HCV infection in a rural population of the Central African Republic (CAR): evidence for three additional subtypes of genotype 4. J Med Virol (1995) 1.01
Hepatitis C virus and autoimmunity: fortuitous association or reality? Gastroenterology (1994) 1.01
Antiatherogenic properties of metformin: the experimental evidence. Diabetes Metab (2003) 0.99
Antineutrophil cytoplasmic autoantibodies: how should the biologist manage them? Clin Rev Allergy Immunol (2008) 0.98
[Epidemiologic and virologic study of hepatitis C virus infections in Morocco]. Gastroenterol Clin Biol (2000) 0.96
Proinflammatory cytokine expression in cervicovaginal secretions of normal and HIV-infected women. Cytokine (1995) 0.95
Lymphopenia in occupational pulmonary silicosis with or without autoimmune disease. Clin Exp Immunol (2001) 0.95
Testing for HCV-RNA in commercial intravenous immunoglobulins. Lancet (1993) 0.94
Automated percutaneous lumbar discectomy versus chemonucleolysis in the treatment of sciatica. A randomized multicenter trial. Spine (Phila Pa 1976) (1993) 0.94
mtDNA haplogroup J: a contributing factor of optic neuritis. Eur J Hum Genet (1999) 0.94
Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects. Br J Clin Pharmacol (1990) 0.93
FibroMeters: a family of blood tests for liver fibrosis. Gastroenterol Clin Biol (2008) 0.93
Virucidal activity of a new hand disinfectant with reduced ethanol content: comparison with other alcohol-based formulations. J Hosp Infect (2005) 0.92
Gender and age at onset in schizophrenia: impact of family history. Am J Psychiatry (1995) 0.92
Upregulation of macrophage lipoprotein lipase in patients with type 2 diabetes: role of peripheral factors. Diabetes (2000) 0.91
Advanced glycation end-products increase monocyte adhesion to retinal endothelial cells through vascular endothelial growth factor-induced ICAM-1 expression: inhibitory effect of antioxidants. J Leukoc Biol (2004) 0.91
Moclobemide versus clomipramine in endogenous depression. A double-blind randomised clinical trial. Br J Psychiatry (1992) 0.90
Three cases of severe subfulminant hepatitis in heart-transplanted patients after nosocomial transmission of a mutant hepatitis B virus. Hepatology (1999) 0.90
[Acute hepatitis after taking enalapril maleate (Renitec)]. Gastroenterol Clin Biol (1987) 0.89
Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia. J Hepatol (1996) 0.89
Echocardiographic features of Candida species endocarditis: 12 cases and a review of published reports. Heart (2001) 0.89
[Viral markers of hepatitis B, C and D and HB vaccination status of a health care team in a rural district of Cameroon]. Med Trop (Mars) (2011) 0.89
Candida endocarditis: role of new antifungal agents. Mycoses (2008) 0.89
[Breast abscess with Salmonella typhi and review of the literature]. J Gynecol Obstet Biol Reprod (Paris) (2007) 0.88
Silicon nephropathy and myeloperoxidase antibodies. Ann Rheum Dis (1994) 0.88
[Mutation analysis of ISDR and V3 domains of hepatitis C virus NS5A region before interferon therapy with or without ribavirin]. Pathol Biol (Paris) (2004) 0.88
Effects of lamivudine on replication of hepatitis B virus in HIV-infected men. Ann Intern Med (1996) 0.87
Sustained disappearance of hepatitis C viremia in patients receiving protease inhibitor treatment for human immunodeficiency virus infection. J Infect Dis (1999) 0.87
Prognosis of vasculitis associated myelodysplasia. Autoimmun Rev (2013) 0.87
The impulsivity rating scale (IRS): preliminary results. Eur Psychiatry (1995) 0.87
Microbubble cloud characterization by nonlinear frequency mixing. J Acoust Soc Am (2011) 0.87
Lack of concordance between plasma markers of cardiovascular risk and intima-media thickness in patients with type 2 diabetes. Diabetes Obes Metab (2004) 0.87
Hepatitis C virus and cryoglobulinemia. N Engl J Med (1993) 0.86
[A motor function measurement scale for neuromuscular diseases - description and validation study]. Rev Neurol (Paris) (2006) 0.86
Differentiating Emery-Dreifuss muscular dystrophy and collagen VI-related myopathies using a specific CT scanner pattern. Neuromuscul Disord (2010) 0.86
Mutations in NS5A region of hepatitis C virus genome correlate with presence of NS5A antibodies and response to interferon therapy for most common European hepatitis C virus genotypes. Hepatology (1998) 0.86
Fibromuscular dysplasia may herald symptomatic recurrence of cervical artery dissection. Cerebrovasc Dis (2007) 0.85
[Antibody avidity: use for the diagnosis of HIV early infection]. Ann Biol Clin (Paris) (2001) 0.85
Replication status and histological features of patients with triple (B, C, D) and dual (B, C) hepatic infections. J Viral Hepat (2000) 0.85
Relevance of Ki-67 and prognostic factors for recurrence/progression of gonadotropic adenomas after first surgery. Eur J Endocrinol (2007) 0.85
Non-O1, non-O139 Vibrio cholerae bacteraemia in a cirrhotic patient. J Med Microbiol (2010) 0.85
Benefits from mianserin augmentation of fluoxetine in patients with major depression non-responders to fluoxetine alone. Acta Psychiatr Scand (2001) 0.84
Pressure measurements at rest and after heavy exercise to detect moderate arterial lesions in athletes. J Vasc Surg (2001) 0.84
Determination and comparison of the pressor effect of tyramine during long-term moclobemide and tranylcypromine treatment in healthy volunteers. Clin Pharmacol Ther (1989) 0.84
Fatal congenital tuberculosis due to a Beijing strain in a premature neonate. J Med Microbiol (2010) 0.84
Anti-myeloperoxidase antibodies and associated diseases. Adv Exp Med Biol (1993) 0.84
[Dynamic study of anti-HIV antibody avidity after cellular immunity restoration under antiretroviral treatment]. Ann Biol Clin (Paris) (2001) 0.84
Distribution of total DNA and cccDNA in serum and PBMCs may reflect the HBV immune status in HBsAg+ and HBsAg- patients coinfected or not with HIV or HCV. Clin Res Hepatol Gastroenterol (2013) 0.84
Clastogenic factor in ischemia-reperfusion injury during open-heart surgery: protective effect of allopurinol. Ann Thorac Surg (1988) 0.84
Hepatitis C virus (HCV) genotype analysis in apparently healthy anti-HCV-positive Parisian blood donors. Transfusion (1996) 0.83
Increased serum immunoglobulin G1 levels in hepatitis C virus infection. Hepatology (1995) 0.83
Proliferative effect of lipoprotein lipase on human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2000) 0.83
European and American suspected and confirmed pulmonary embolism populations: comparison and analysis. J Thromb Haemost (2012) 0.83
Oral lichen planus and hepatitis C virus infection: a fortuitous association? Arch Dermatol (1997) 0.83
A comparative evaluation of the sensitivity of five anti-hepatitis C virus immunoblot assays. Vox Sang (1998) 0.82
[Palindromic rheumatism. Immunologic survey and study of development in 43 cases]. Rev Rhum Mal Osteoartic (1987) 0.82
Indeterminate third-generation recombinant immunoblot assay in hepatitis C virus infection. Group d'Etudes Moléculaires des Hépatites (GEMHEP). J Hepatol (1994) 0.82
Hypoglycemic symptoms and decreased beta-adrenergic sensitivity in insulin-dependent diabetic patients. Diabetes Care (1988) 0.82
The "functional" popliteal entrapment syndrome. Int Angiol (1986) 0.82
Detection of seminal antibodies to human immunodeficiency virus in vaginal secretions after sexual intercourse: possible means of preventing the risk of human immunodeficiency virus transmission in a rape victim. J Med Virol (1995) 0.82
[Comparative effects of ginkgo biloba extracts on psychomotor performances and memory in healthy subjects]. Therapie (1991) 0.81
Coxiella burnetii infection among subjects infected with HIV type 1 in the Central African Republic. Eur J Clin Microbiol Infect Dis (1993) 0.81
Predictors of short-term deterioration and compliance in psychiatric emergency patients: a prospective study of 457 patients referred to the emergency room of a general hospital. Psychiatry Res (2001) 0.81